LAUSR

Previous investigations showed inconsistent results for comparison in renal recovery, in‐hospital, and in‐intensive care unit (ICU) mortalities between acute kidney injury (AKI) patients treated with continuous renal replacement therapy (CRRT) and some kinds of intermittent renal replacement therapies (IRRTs). We systematically searched for articles published in the databases (PubMed, Web of Science, EMBASE, Medline, and Google Scholar) until June 2019. We made all statistical analysis using STATA 12.0 software. In the present meta‐analysis, relative risks with 95% confidence intervals were calculated for binary outcomes (renal recovery status or mortality). The present study indicated no significant differences in renal recovery, in‐hospital mortality, and in‐ICU mortality between AKI patients given CRRT and those given sustained low‐efficiency dialysis (SLED). Additionally, the study showed no significant difference in in‐hospital mortality between AKI patients given CRRT and those given intermittent hemodialysis (IHD), whereas elevated in‐ICU mortality was detected in AKI patients given CRRT, compared to those given IHD. The three modalities (CRRT, IHD, and SLED) have their own advantages and disadvantages. More rigorous trials design with large cohort should be made to explore the differences in renal recovery, in‐hospital, and in‐ICU mortalities between different kinds of RRTs.